Skip to main content
. 2022 Jun 10;15:1771–1784. doi: 10.2147/DMSO.S354579

Table 4.

Clinical Features and Biochemical Profile of T2D Patients According to Alleles of Met408Val (rs628031) SLC22A1/OCT1 Polymorphism in Monotherapy with Metformin

n= 83 Reference Values Allele G Allele A p-value
n (%) 63 (76) 20 (24)
Age (years) 58.6 ± 11.8 55.0 ± 11.8 0.170
Sex, F/M 39/24 14/6 0.600
Years with T2D 5.3 ± 6.4 2.5 ± 2.7 0.047a
Therapy time (years) 5.0 ± 5.9 2.2 ± 2.1 0.038a
Anthropometric
BMI (Kg/m2) 18.5–24.9 29.4 ± 4.9 32.1 ± 8.3 0.426
Normal weight n (%) 10 (16) 2 (10)
Overweight n (%) 15 (24) 10 (50) 0.215
Obesity n (%) 22 (35) 8 (40)
Total body fat (%) M: 12–20 F: 20–30 34.3 ± 7.9 36.1 ± 8.5 0.476
WC (cm) M:<90 F:<80 99.3 ± 11.9 106.2 ± 20.0 0.567
Glycemic profile
Glucose (mg/dL) < 110 127 ± 43.2 124 ± 43.7 0.454
HbA1c (%) < 6.5 6.6 ± 1.3 6.7 ± 1.9 0.496
Glyc Ctrl (%HbA1c) <7.0 51 (81) 15 (75) 1.000
TyG index (ratio) < 8.31 9.0 ± 0.5 8.9 ± 0.5 0.532
I.R. (TyG index) - 58 (92.1) 19 (95.0) 0.568
Lipid Profile
TC (mg/dL) < 200 176 ± 30.8 174 ± 31.9 0.717
TG (mg/dL) < 150 143 ± 63.3 132 ± 40.3 0.862
HDL-c (mg/dL) >50 49 ± 11.1 46 ± 9.9 0.696
Non-HDL-c (mg/dL) <130 127 ± 29.6 128 ± 28.7 0.949
LDL-c (mg/dL) <100 100 ± 26.8 102 ± 23.0 0.746

Notes: Values are presented as mean ± standard deviations, frequencies, and percentages. aThe t-student test was the statistical approach, p<0.05.

Abbreviations: T2D, Type 2 Diabetes; F, Female; M, Male; BMI, Body Mass Index; WC, Waist Circumference; HbA1c, Glycated hemoglobin; TyG index, Triglyceride-Glucose index; I.R, Insulin Resistance; Glyc Ctrl, Glycemic control; TC, Total-cholesterol; TG, Triglycerides; HDL-c, High-density lipoprotein cholesterol; Non-HDL-c, Non-high-density lipoprotein cholesterol; LDL-c, Low-density lipoprotein cholesterol; mg, milligrams; dL, deciliters.